INDIAN JOURNAL OF PHARMACOLOGY

Scope & Guideline

Innovating drug action insights to enhance therapeutic practices.

Introduction

Welcome to your portal for understanding INDIAN JOURNAL OF PHARMACOLOGY, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN0253-7613
PublisherWOLTERS KLUWER MEDKNOW PUBLICATIONS
Support Open AccessNo
CountryIndia
TypeJournal
Convergefrom 1978 to 1980, 1982, from 1984 to 1986, from 1994 to 2024
AbbreviationINDIAN J PHARMACOL / Indian J. Pharmacol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressWOLTERS KLUWER INDIA PVT LTD, A-202, 2ND FLR, QUBE, C T S NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra 400059, INDIA

Aims and Scopes

The Indian Journal of Pharmacology focuses on various aspects of pharmacology, including drug development, clinical pharmacology, pharmacovigilance, and the therapeutic efficacy of medicinal compounds. It aims to bridge the gap between laboratory research and clinical practice, providing a platform for innovative studies and reviews that advance the field of pharmacology.
  1. Clinical Pharmacology and Therapeutics:
    Research on the effects of drugs in humans, focusing on their efficacy, safety, and optimal use in clinical settings. This includes studies on drug interactions, adverse effects, and therapeutic outcomes.
  2. Pharmacovigilance and Drug Safety:
    Studies that monitor and evaluate the safety of medications post-marketing, including adverse drug reactions and their management. The journal emphasizes the importance of reporting and analyzing drug-related adverse events.
  3. Natural Products and Traditional Medicine:
    Research investigating the pharmacological properties of natural compounds, including herbal medicines and their efficacy in treating various diseases. This area highlights the relevance of traditional medicine in modern pharmacological practices.
  4. Innovations in Drug Development:
    Papers focusing on new drug formulations, delivery systems, and therapeutic strategies, including the use of nanotechnology and computational methods in drug discovery.
  5. Experimental and Preclinical Studies:
    Research utilizing animal models to understand drug mechanisms, efficacy, and safety before clinical trials. This includes studies on pharmacokinetics and pharmacodynamics.
  6. Public Health and Epidemiology:
    Research addressing the impact of pharmacological interventions on public health, including studies on drug accessibility, prescribing patterns, and the role of pharmacology in managing infectious diseases.
Recent publications in the Indian Journal of Pharmacology indicate several emerging themes that reflect current challenges and advancements in the field. These trends highlight the journal's responsiveness to contemporary issues in pharmacology and medicine.
  1. Impact of COVID-19 on Pharmacology:
    A significant number of recent articles address the pharmacological implications of COVID-19, including drug repurposing, vaccine development, and management of post-COVID complications, underscoring the pandemic's influence on research priorities.
  2. Artificial Intelligence and Machine Learning in Drug Development:
    There is a growing interest in the application of AI and machine learning in pharmacological research, particularly in experimental design and data analysis, showcasing a trend towards integrating technology in drug discovery.
  3. Neuropharmacology and Mental Health:
    An increasing number of studies focus on neuropharmacological agents and their effects on mental health disorders, reflecting a broader understanding of the importance of mental health in pharmacological research.
  4. Natural Products and Phytotherapy:
    Research on natural products is gaining momentum, with a focus on their pharmacological potential and mechanisms of action, indicating a resurgence in interest in herbal medicine and its therapeutic applications.
  5. Pharmacovigilance and Safety Monitoring:
    There is an upward trend in research dedicated to pharmacovigilance, emphasizing the need for ongoing safety monitoring of medications and the importance of understanding adverse drug reactions in clinical practice.

Declining or Waning

While the Indian Journal of Pharmacology has consistently published papers across a wide range of topics, certain themes have shown a decline in prominence over recent years. This may reflect shifts in research priorities or emerging interests within the field.
  1. Traditional and Alternative Medicine:
    Although still relevant, there has been a noticeable decline in the number of papers focusing solely on traditional and alternative medicinal practices. This could indicate a shift towards more evidence-based approaches in pharmacology.
  2. Basic Pharmacological Mechanisms:
    Research solely dedicated to fundamental pharmacological mechanisms appears to be waning, as the focus moves towards clinical applications and translational research.
  3. Pharmacogenetics and Personalized Medicine:
    While once a hot topic, there seems to be a decrease in publications centered on pharmacogenetics, possibly due to a greater emphasis on broader clinical applications rather than genetic factors influencing drug responses.
  4. Drug Regulation and Policy:
    There has been less emphasis on studies related to drug regulation and policy in recent publications, suggesting a potential gap in exploring the implications of pharmacological practices on healthcare systems.

Similar Journals

FUNDAMENTAL & CLINICAL PHARMACOLOGY

Empowering healthcare through innovative pharmacological research.
Publisher: WILEYISSN: 0767-3981Frequency: 6 issues/year

FUNDAMENTAL & CLINICAL PHARMACOLOGY is a distinguished journal dedicated to advancing the fields of pharmacology and clinical medicine. Published by WILEY, this journal serves as a pivotal platform for researchers, healthcare professionals, and students alike to disseminate innovative research findings and clinical applications. With an impressive history spanning from 1987 to 2024, it has consistently maintained its relevance in the scientific community, evidenced by its Q2 quartile ranking in both Pharmacology and Pharmacology (medical) categories for 2023. The journal's diverse publication range, which includes original research articles, reviews, and clinical studies, helps bridge the gap between fundamental research and practical application in healthcare settings. Although it does not offer open access, its rigorous peer-review process ensures that published content meets the highest scholarly standards, making it a vital resource for those aiming to stay at the forefront of pharmacological sciences.

ANNALS OF PHARMACOTHERAPY

Empowering the Next Generation of Pharmacotherapy
Publisher: SAGE PUBLICATIONS INCISSN: 1060-0280Frequency: 12 issues/year

ANNALS OF PHARMACOTHERAPY, published by SAGE PUBLICATIONS INC, is a leading journal in the realm of pharmacology and therapeutic science, dedicated to advancing research, clinical practice, and education in the field of medicine. With a solid history dating back to its first publication in 1981, this journal offers a platform for high-quality research articles that explore the latest innovations and methodologies in pharmacotherapy. Although it operates under a subscription-based model, the journal maintains a robust academic reputation, reflected in its Scopus ranking in the 68th percentile within the category of Medicine - Pharmacology (Rank #85/272). The impact factor is continually evolving, as is the scope, which encompasses a diverse range of topics from clinical trials to the therapeutic applications of newly-developed drugs. Researchers, professionals, and students alike will find valuable insights and cutting-edge research in the ANNALS OF PHARMACOTHERAPY, making it an essential resource for anyone engaged in the field of pharmacology.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Exploring Innovations in Drug Action and Safety
Publisher: WILEYISSN: 1742-7835Frequency: 12 issues/year

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, published by WILEY, serves as a vital resource in the fields of medicine, pharmacology, and toxicology. With an ISSN of 1742-7835 and E-ISSN 1742-7843, this journal has established a robust reputation, reflected in its Q2 classification across its categories in 2023. It aims to disseminate high-quality research and reviews that bridge the gap between basic scientific findings and clinical applications. Operating from the United States with an address at 111 RIVER ST, HOBOKEN 07030-5774, NJ, this journal focuses on the intersection of drug action and toxicity, making it an essential platform for researchers, healthcare professionals, and students. With a converged publication timeline from 2004 to 2024, BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY continues to make significant contributions to understanding pharmacological treatments and toxicological challenges. Open access options are available to broaden the reach and impact of its published work.

Drug Research

Exploring New Horizons in Drug Discovery
Publisher: GEORG THIEME VERLAG KGISSN: 2194-9379Frequency: 9 issues/year

Drug Research, published by GEORG THIEME VERLAG KG, is a pivotal journal housed in the vibrant realm of pharmacology and drug discovery. With a commitment to advancing the understanding of medicinal substances, this journal serves as an essential resource for researchers, professionals, and students dedicated to the field. The journal boasts an ISSN of 2194-9379 and an E-ISSN of 2194-9387, reflecting its dual commitment to print and digital accessibility. Despite its status as a Q3 journal in both Drug Discovery and Miscellaneous Medicine categories as of 2023, it continues to offer valuable insights with a focus on the latest innovations, methodologies, and findings in drug research. Based in Germany, Drug Research promotes scholarly communication and collaboration within the scientific community, ensuring that its contributions remain impactful in shaping future therapeutic discoveries. The journal is indexed in relevant databases, enhancing its visibility and reach, thus fostering a robust academic dialogue.

BMC Pharmacology & Toxicology

Pioneering research for a safer, healthier world.
Publisher: BMCISSN: Frequency: 1 issue/year

Welcome to BMC Pharmacology & Toxicology, a premier open-access journal dedicated to advancing the fields of pharmacology and toxicology. Published by BMC since 2012, this esteemed journal offers a platform for researchers, professionals, and students to disseminate cutting-edge research and innovative findings that explore the intricate interactions between drugs and biological systems. With its robust Q2 ranking in both general medicine and pharmacology categories for 2023, BMC Pharmacology & Toxicology is recognized for its significant contributions to the academic community, reflected in its strategic positioning within the 61st and 49th percentiles in Scopus rankings for related disciplines. The journal's commitment to open access ensures that vital research is accessible to a global audience, fostering collaboration and informed discussions. We invite you to engage with the latest studies, reviews, and innovative methodologies that shape the future of pharmacological and toxicological sciences.

BIOLOGICAL & PHARMACEUTICAL BULLETIN

Bridging the Gap Between Science and Healthcare
Publisher: PHARMACEUTICAL SOC JAPANISSN: 0918-6158Frequency: 12 issues/year

BIOLOGICAL & PHARMACEUTICAL BULLETIN, published by the PHARMACEUTICAL SOC JAPAN, is a prominent peer-reviewed journal that serves the fields of medicine, pharmaceutical science, and pharmacology. With an ISSN of 0918-6158 and an E-ISSN of 1347-5215, this publication has been crucial in disseminating innovative research since its inception in 1993, and it continues to contribute significantly to the body of knowledge as it converges towards 2024. Despite being classified as a non-open access journal, it maintains a respectable Q3 ranking in Medicine (miscellaneous) and Q2 in Pharmaceutical Science, highlighting its critical role in advancing scientific discourse in these areas. With Scopus rankings placing it in the 51st percentile for Pharmaceutical Science and 38th percentile for Pharmacology, BIOLOGICAL & PHARMACEUTICAL BULLETIN is an essential resource for researchers, professionals, and students looking to stay abreast of cutting-edge developments and trends in biomedicine and drug development.

European Journal of Pharmacology

Unveiling groundbreaking research in pharmacokinetics and toxicology.
Publisher: ELSEVIERISSN: 0014-2999Frequency: 24 issues/year

The European Journal of Pharmacology, a prestigious publication by Elsevier, serves as a vital resource in the field of pharmacology, offering rich insights into drug development and therapeutic applications. Since its inception in 1967, this journal has evolved to encompass groundbreaking research, including pharmacokinetics, toxicology, and innovative pharmacological methodologies, making it an essential platform for researchers and professionals alike. With an impressive impact factor that places it in the Q1 category of pharmacological journals and a Scopus ranking of #49 out of 313, the journal is recognized in the 84th percentile within its category, solidifying its significance in the academic community. Although the journal is not open access, it continues to attract contributions from leading scientists worldwide, ensuring that cutting-edge findings are disseminated effectively. The European Journal of Pharmacology not only highlights advancements in drug discovery and clinical applications but also promotes interdisciplinary collaboration, ultimately contributing to the progress of healthcare globally.

JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS

Pioneering Pharmacological Solutions for Veterinary Challenges
Publisher: WILEYISSN: 0140-7783Frequency: 6 issues/year

JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS is a crucial publication in the field of veterinary medicine, dedicated to advancing knowledge and practices related to pharmacology and therapeutic interventions in animals. Published by WILEY, this peer-reviewed journal has been a reliable source of innovative research since its inception in 1978, and it continues to play an integral role in shaping veterinary pharmacology through its commitment to high-quality scientific discourse. With an impact factor reflective of its robust academic standing, the journal is categorized in the Q3 quartile for Pharmacology and Q2 for Veterinary (miscellaneous) as of 2023, highlighting its relevance and significance within these domains. It is indexed in Scopus with commendable rankings, particularly in General Veterinary, where it ranks #45 out of 194, placing it in the 77th percentile. This journal not only offers a platform for original research articles but also caters to the dissemination of practical applications and reviews that are essential for veterinarians, researchers, and students alike in enhancing animal health and welfare. Although not an open-access publication, its contributions remain accessible to those engaged in the veterinary sciences through institutional subscriptions. The journal's enduring legacy and forward-looking approach make it a vital resource for anyone interested in veterinary therapeutics and pharmacology.

Ars Pharmaceutica

Unveiling the art of pharmaceuticals for a better tomorrow.
Publisher: UNIV GRANADA, EDITORIALISSN: 0004-2927Frequency: 4 issues/year

Ars Pharmaceutica is a distinguished open-access journal published by UNIV GRANADA, EDITORIAL, that has been at the forefront of pharmaceutical sciences since its establishment. With ISSN 0004-2927 and E-ISSN 2340-9894, this journal aims to disseminate high-quality research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of the field. With a historical scope that spans from 1980 to 2017, it has played a pivotal role in shaping the discourse surrounding pharmaceutical science and its intersection with the arts and humanities. Although currently ranked within the 13th percentile in Scopus for Pharmaceutical Science and the 11th percentile for History and Philosophy of Science, Ars Pharmaceutica continues to uphold its commitment to academic excellence and innovation. By providing a platform for open-access research, it encourages collaboration and knowledge sharing among researchers, professionals, and students, thus enhancing the broader understanding of pharmaceutical developments and their societal implications.

Biuletyn Wydzialu Farmaceutycznego Warszawskiego Uniwersytetu Medycznego

Advancing Pharmaceutical Knowledge in the Heart of Warsaw
Publisher: MEDICAL UNIV WARSAWISSN: 2080-1602Frequency:

Biuletyn Wydzialu Farmaceutycznego Warszawskiego Uniwersytetu Medycznego is a prestigious academic journal dedicated to publishing high-quality research in the field of pharmaceutical sciences. Published by the Medical University of Warsaw, this journal serves as a vital platform for researchers, professionals, and students to share their findings and advances in drug development, pharmaceutical sciences, and clinical practices. With its ISSN 2080-1602, it upholds rigorous standards of academic integrity and relevance to the pharmaceutical community. Although it currently does not offer open access, the journal plays a crucial role in disseminating knowledge, contributing to the advancement of pharmacy and health sciences. Located in Warsaw, Poland, it aims to bridge gaps in pharmaceutical research and practice, fostering collaboration and innovation among professionals in the field.